Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.

about

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.

Item

http://www.wikidata.org/entity/Q52727412

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Prediction of cervical cancer ...... scenarios: a modelling study.

@en

Prediction of cervical cancer ...... scenarios: a modelling study.

@nl

type

Item

label

Prediction of cervical cancer ...... scenarios: a modelling study.

@en

Prediction of cervical cancer ...... scenarios: a modelling study.

@nl

prefLabel

Prediction of cervical cancer ...... scenarios: a modelling study.

@en

Prediction of cervical cancer ...... scenarios: a modelling study.

@nl

P1476

Prediction of cervical cancer ...... scenarios: a modelling study.

@en

P2093

Francesca Pesola

http://www.w3.org/2001/XMLSchema#string

Peter Windridge

http://www.w3.org/2001/XMLSchema#string

P2860

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?

Analysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70 years: the CRICERVA study.

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model.

Understanding the heterogeneity of cervical cancer screening non-participants: Data from a national sample of British women.

Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.

Cancer prevention in primary care. Screening for cervical cancer.

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes.

Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.

Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting.

P304

e34-e43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S2468-2667(17)30222-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rebecca Landy

Alejandra Castanon

Peter Sasieni

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29307386

http://www.w3.org/2001/XMLSchema#string

P932

5765529

http://www.w3.org/2001/XMLSchema#string